• PExA received a European patent on September 23, 2026, covering analysis of exhaled particles from patients receiving mechanical ventilation.
• The patented technology uses particle data to monitor lung conditions and help optimize ventilation treatment.
• European and Chinese patent authorities issued positive notices ahead of granting patents for a sample preparation technology.
• The sample preparation invention is already patented in the US.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PExA AB published the original content used to generate this news brief via Cision (Ref. ID: 202610290400BITN____UKPR__SV_20261029-BIT-1744-0) on October 29, 2026, and is solely responsible for the information contained therein.